An appeals court has reimposed penalties against the Construction, Forestry, Maritime, Mining and Energy Union, its NSW branch and nine officials for unlawful industrial action at Barangaroo, but dropped the total fine from $2.5 million to $1.7 million.
The US International Trade Commission has opened an investigation into alleged patent infringement by solar companies JinkoSolar, LONGi Solar and REC Group, after Korean solar company Hanwha Q CELLS filed two related proceedings in Australian court alleging the companies are infringing its solar technology.
Bega Cheese has presuaded a court to allow a partner from Addisons Lawyers to access select confidential documents, expanding the confidentiality regime at the heart of its dispute with Fonterra Brands over an allegedly violated trade mark licence agreement.
A judge has scheduled a two-day hearing to hear a dispute between investment group Caason Investments, a lead applicant in a shareholder class action against defunct laser technology company Arasor that settled last year for $19.25 million, and Singapore-based litigation funder International Litigation Partners over personal costs allegedly owed to the investment group under a “secret” side agreement.
Two generic pharmaceutical companies, Generic Partners and Apotex, have filed cross-claims alleging that Neurim Pharmaceuticals’ patent for its insomnia drug Circadin is invalid and should be revoked.
Litigation funder Litigation Capital Management will snap up 30 percent of a confidential settlement amount that KPMG has fought to keep under wraps in a shareholder class action over a failed $830 million hostile takeover bid of mining firm Discovery Metals.
A judge has refused an application by horse vaccine maker Zoetis for $450,000 as security for costs in an unfunded class action alleging misleading claims by the pharmaceutical company, saying while he had the power to make the order sought, the “principled exercise” of his discretion was to reject the bid.
A judge has agreed to postpone a trial against logistics provider GetSwift until next year when a class action and a lawsuit by the Australian Securities and Investments Commission related to the company’s disclosures will be heard consecutively rather than concurrently.
IP Australia has ordered biotech firm MacroGenics to amend its patent for a type of polypeptide used in treatments for cancer, autoimmune disorders and other diseases after a successful opposition from the chairman of intellectual property boutique Wrays.
Maurice Blackburn is investigating a possible shareholder class action against construction company Lendlease over allegedly inadequate disclosures relating to its engineering and services business, which includes the NorthConnex tunnel road project in Sydney.